Zhejiang Sci-Tech University, Zhejiang, HangZhou, China.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426.
List the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility.
The keywords of "remdesivir", "COVID-19" and "SARS-CoV-2" were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19.
In this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug.
According to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.
列举瑞德西韦在 COVID-19 中的临床数据，并尝试进行客观评价，分析其可行性。
系统检索 PubMed 和 Web of Science 中“remdesivir”“COVID-19”和“SARS-CoV-2”的关键词，去除重复后，对瑞德西韦治疗 COVID-19 的相关文章、信件和评论进行总结。
在本次综述中，我们总结了使用瑞德西韦治疗 COVID-19 的临床病例，分析了最终的治疗结果，判断该药物对 COVID-19 的治疗是否有效，同时也关注了药物的副作用。
根据临床结果发现，瑞德西韦在治疗 COVID-19 方面是有效的。该药物有一定副作用，但症状较轻，停药后立即消失。
